MatsukiyoCocokara & Co.
Matsukiyo Kurakara & Company Co., Ltd. Q1 Consolidated Financial Results for the Year Ending March 2027
Consolidated net sales for the first quarter of the fiscal year ending March 2027 were 289,348 million yen, up 5.7% YoY. Operating income was 21,487 million yen, up 8.5% YoY; ordinary income was 22,822 million yen; net income attributable to owners of parent was 14,865 million yen. Full-year guidance remains unchanged. Dividend forecast for the fiscal year ending March 2027 is 56.00 yen (including per-share interim).
Key Figures
- Sales: 289,348百万円（YoY up 5.7%）
- Operating income: 21,487百万円（ YoY up 8.5%）
- Net income attributable to owners of parent: 14,865百万円（ YoY up 14.9%）
AI要約
Performance overview
This quarter's net sales were 289,348 million yen (up 5.7% YoY), operating income was 21,487 million yen (up 8.5% YoY), ordinary income was 22,822 million yen (up 8.8% YoY), and net income attributable to owners of parent was 14,865 million yen (up 14.9% YoY), with each indicator exceeding the prior year's results. Segment contributions from Matsumoto Kiyoshi Group operations and the Management Support segment supported the overall sales growth, and there is no change to the full-year guidance. The dividend for the fiscal year 2027 is expected to total 56.00 yen.
Outlook and strategy
The company will continue its policy of three pillars—differentiation strategy, investment strategy, and social contribution—aiming to achieve the group’s management targets by March 2031. It will push store openings in major metropolitan areas, integration of dispensing functions, expanded consolidation with And Company and Universal Drug, and improved customer convenience through digital investment. Quarterly results reflect progress in these initiatives, and it is expected to continue improving profitability by segment and expanding the store network going forward.
Matsukiyo Kurakara & Company Co., Ltd.
Company overview · Stock price · Financial data · All IR
